A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD

NCT07658339 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DRUG: HSK39004 Inhalation Suspension
DRUG: Placebo control

Sponsor

Haisco Pharmaceutical Group Co., Ltd.